REQUEST A DEMO
Total
USD $0.00
Search more companies

Evropa Lek Pharma D.O.O. Beograd (Serbia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Evropa Lek Pharma D.O.O. Beograd Profile Updated: October 02, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English Download a sample report

Evropa Lek Pharma D.O.O. Beograd is an enterprise in Serbia, with the main office in Belgrade. The company operates in the Drugs and Druggists' Sundries Merchant Wholesalers sector. The company was established on October 22, 2000. There are currently 80 (2024) people employed by Evropa Lek Pharma D.O.O. Beograd. There was a net sales revenue increase of 6.14% reported in Evropa Lek Pharma D.O.O. Beograd’s latest financial highlights for 2025. Its’ total assets recorded a growth of 42.78%. The net profit margin of Evropa Lek Pharma D.O.O. Beograd increased by 13.91% in 2025.

Headquarters
Bore Stankovica 2
Belgrade; Belgrade;

Contact Details: Purchase the Evropa Lek Pharma D.O.O. Beograd report to view the information.

Website: http://www.elpharma.com

Basic Information
Total Employees:
Purchase the Evropa Lek Pharma D.O.O. Beograd report to view the information.
Registered Capital:
Purchase the Evropa Lek Pharma D.O.O. Beograd report to view the information.
Financial Auditors:
Purchase the Evropa Lek Pharma D.O.O. Beograd report to view the information.
Incorporation Date:
October 22, 2000
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Representative
Ownership Details
Purchase this report to view the information.
100%
Subsidiaries
Phoenix It Services
100%
El Pharma D.O.O. (Bosnia and Herzegovina)
Evropa Lek Farma D.O.O.E.L. (North Macedonia)
Company Performance
Financial values in the chart are available after Evropa Lek Pharma D.O.O. Beograd report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RSD. Absolute financial data is included in the purchased report.
Net sales revenue
6.14%▲
Total Operating Revenue
6.22%▲
Operating Profit
-24.52%▼
EBITDA
-22.35%▼
Net Profit/Loss for the Period
261.73%▲
Total Assets
42.78%▲
Total Equity
51.79%▲
Operating Profit Margin
-2.08%▼
Net Profit Margin
13.91%▲
Return on Equity (ROE)
29.09%▲
Debt / Equity
23.54%▲
Quick Ratio
0.71%▲
Cash Ratio
0.67%▲

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?